Cite

HARVARD Citation

    Tournoy, K. et al. (2018). Does nivolumab for progressed metastatic lung cancer fulfill its promises? An efficacy and safety analysis in 20 general hospitals. Lung cancer. pp. 49-55. [Online]. 
  
Back to record